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Abstract: 
New advanced manufacturing technologies under the alias of additive biomanufacturing 
allow the design and fabrication a range of products from pre-operative models, cutting 
guides, medical devices to scaffolds. The printing in 3-dimensions of cells, extracellular 
matrix (ECM) and biomaterials (bioinks, powders etc.) to generate in vitro and/or in vivo 
tissue analogue structures; this has been termed bioprinting. To further advance in additive 
biomanufacturing, there are many aspects that we can learn from the wider additive 
manufacturing (AM) industry, which have progressed tremendously since its introductions 
into the manufacturing sector. Firstly, this review gives an overview of additive 
manufacturing and both industry and academia efforts in addressing specific challenges in 
the AM technologies to drive towards AM-enabled industrial revolution. After which, 
considerations of poly(lactides) as biomaterial in additive biomanufacturing was discussed. 
Challenges in wider additive biomanufacturing field was discussed in terms of (a) 
biomaterials , (b) computer-aided design, engineering and manufacturing, (c) AM and 
additive biomanufacturing printers hardware, and (d) system integration. Finally, the outlook 
for additive biomanufacturing was discussed. 
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1 Introduction 
The term Additive Manufacturing (AM) refers to a broad range of techniques that turn three-
dimensional (3D) digital data into physical objects, and has been defined by the American 
Society for Testing and Materials (ASTM) International Committee F42 as the “process of 
joining materials to make objects from 3D model data, usually layer upon layer, as opposed 
to subtractive manufacturing methodologies” [1]. Commonly defined in the consumer market 
as 3D printing, AM, as defined in the manufacturing industry, is a suite of computer-
automated processes that fabricates physical 3D objects layer by layer from computer-aided 
design (CAD) models using metallic, plastic, ceramic, composite and biological materials.  
One might argue that the ideation of AM technology can be traced back to almost 150 years 
ago, arising from topography and photosculpture, which uses a technique which can be 
viewed as manual “cut and stack” approaches to building a freeform object in a layer-by-
layer fashion [2]. However, the development of modern AM techniques did not kick-start until 
the 1950s, with the patent filed by Munz of a system that features the present day 
stereolithography (SLA) techniques [2, 3]. The process proposed by Munz can selectively 
expose and fix a transparent photo emulsion in a layer-wise fashion, then, manually carved 
or photochemically etched out the fixed photo emulsion to create a 3D object. Subsequently, 
in 1968, Swainson proposed and later patented a process to directly fabricate a plastic 
pattern by selective, three dimensional polymerisation of a photosensitive polymer at the 
intersection of two laser beams [4]. However, the first truly successful viable AM process 
was effectively a powder deposition method with an energy beam proposed by Ciraud in 
1972 [2, 5]. Since then, AM continued to evolve and blossom into a plethora of processes, 
including stereolithography (SLA), 3D Printing (3DP), Fused Deposition Modelling (FDM), 
Selective Laser Sintering (SLS), Selective Laser Melting (SLM), Laminated Object 
Manufacturing (LOM), Laser Metal Deposition (LMD), Inkjet Printing, and others [6].  
2 Moving towards Direct Manufacturing 
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At an early stage, AM processes were predominantly used by engineers to present their 
designs through physical models (also termed prototypes); thus, these technologies in the 
1990s got the name “Rapid Prototyping”. In recent years, the vision of the broader 
application of AM goes beyond the creation of prototypes, marching into the era of “Direct 
Manufacturing”, a term to describe the production of end-use components [7]. This is mainly 
driven by the various emerging AM industry sectors, each taking care of the development of 
appropriate software, hardware and new materials. The convergence of these AM industry 
segments greatly improves the machine feasibility and the printed-parts quality. As AM 
becomes both a disruptive and transforming technology, its impact continues to grow into 
various industries i.e. aviation, automotive, electronics, furniture, fashion, medical and others. 
A recent report on AM published by Wohler Associates indicated that the global AM industry 
grew 34.9% in 2013, reaching a total market value of $3.07B. It is projected that the total 
market value for AM industry will approach $6B by 2017 [8].  
2.1 Aviation & automotive industry  
AM has a major impact on many industries and is increasingly becoming important as it 
allows freedom of design and greatly reduced time-to-market. The aviation industry has 
partially adopted AM technology into their manufacturing processes, as most products are 
geometrically complex and manufactured in small batch size with high unit costs. For 
example, GE Aviation (GEA) has successfully developed a fuel nozzle, a component for 
flight engine fuel delivery system, using AM technology, more specifically, the direct metal 
laser sintering (DMLS) technique. The AM process enables the manufacturing of the fuel 
nozzle in one single step as opposed to the traditional manufacturing process, which made 
the fuel nozzle out of 20 different parts that were later assembled into one single unit. 
Additionally, the design freedom of AM has enabled the engineers to revise and refine the 
fuel nozzle design, resulting in a 5 times increased fuel delivery system and 25% weight 
reduction as compared to its predecessor [9]. While others have introduced small AM parts 
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to their large products, Rolls-Royce has been determined to push the boundaries of AM and 
has printed a 1.5 m (diameter) titanium front bearing housing for a jet engine [10].  
Similarly, AM is also widely spread within the automotive industry, from concept modelling, 
functional testing, direct manufacturing to production planning. However, the use of AM is 
still focused on the manufacture of prototypes during the development stage, and 
manufacturing is limited to small, complex and non-safety-relevant components within a 
small series, as process reliability and consistency of products is still limited [7].  
2.2 Furniture & Fashion industry  
The growing complexity of shapes and spaces in contemporary design has driven the 
furniture and fashion industry into adapting AM [11]. Since the safety compliances for the 
products developed by these industries are less demanding compared to the aviation and 
automotive industry, AM has been widely adopted, producing design-driven products that 
would not have been possible to manufacture using traditional machining technologies [7, 
12].  
2.3 Dental and medical industry  
Both the dental and medical industries are adapting AM technologies for the manufacturing 
of products mainly due to the fact that individualisation and mass customisation are 
becoming progressively important, as patients expect custom-size fitting products.  
The dental industry is experiencing a digital revolution at present, moving away from 
conventional casting and machining methods to digital dental technology with AM at the 
forefront of the revolution [13, 14]. Using AM, the requirements of individual production can 
be met and hand-crafted processes become obsolete, slashing the cost of production by 
almost 50% [15]. This is mainly due to the efficiency and capabilities of the system on 
production of customised parts, whereby 450 units of crowns and bridges can be produced a 
day, as opposed to 20 per day using the conventional casting method [16].  
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In the medical industry, AM technologies are currently utilised for the manufacturing of 
medical devices such as implants and prosthetics [17, 18], as well as planning tools for 
surgeries [19, 20]. Taking metallic orthopaedic implants as an example, the implant’s design 
can be customised to the patient’s anatomy, avoiding the need of manual adjustment of the 
implant during surgery and potentially diminishing the stress shielding effect (reduction in 
bone density as a result of removal of normal stress from the bone by an implant) [17]. 
Leveraging on the AM technologies, porosity can be introduced into selected regions of the 
implant, promoting osseointegration (direct structural and functional connection between 
living bone and the surface of artificial implant), as bone growth into the void spaces within 
the implants. Such implants have been successfully manufactured and market by Ala Ortho 
S.R.L (Italy) and LimaCorporate S.P.A (Italy). The medical prosthetic sector has also 
adapted AM technologies, as conventionally made prostheses are often expensive; therefore, 
replacements/upgrades were often avoided. This especially has an impact on younger 
patients who need prosthetic replacement as their bodies grow. In these cases, AM has 
been successful in providing affordable plastic-built prosthetic parts while preserving its 
functionality. In 2013, the e-Nable community was established to provide free 3D printed 
prosthetic devices to those who reach out to them [21]. 
Although AM is gradually penetrating the manufacturing process of different industry sectors, 
there are yet many challenges ahead, which need to be addressed and solved in order to 
achieve full integration of AM technologies into the modern manufacturing processes, truly 
heralding the era of Direct Manufacturing.  
3 Effort to address specific challenges for AM-enable industrial revolution 
The applications of AM techniques for Direct Manufacturing in the various industry sectors 
are the result of combined efforts of academia, industry and the international standards 
development agencies. 
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3.1 Standards development for AM technologies 
To help stimulate research and encourage the wide-spread implementation of technology, 
international standards for AM are continuously being developed by the ASTM and 
International Organisation for Standardisation (ISO). These standards define terminology, 
specify procedures for measuring the performance of different production processes, ensure 
the quality of the end products, and specify procedures for the calibration of additive 
manufacturing machines. The establishment of an industrial standardised terminology for 
AM by the ASTM International in 2012 has since benefited the research and development 
efforts in the field of AM. This resulted in the industrial adaptation of AM technologies, 
initially as a tool for rapid prototyping and now moving towards direct manufacturing. 
Prior to the introduction of the ASTM F2782 standard which defined AM terminology, the 
term additive fabrication, additive processes, additive techniques, additive layer 
manufacturing, layer manufacturing, rapid prototyping and freeform fabrication were used 
interchangeably in the literature to describe the technologies which now fall under the 
canopy of AM. Under the authority of the working group, the ASTM F2792 has unified the 
field in respect to terminology.  
Additionally, the ASTM F42 and ISO/TC 261 (committee for AM standards) has hosted joint 
planning sessions in 2013, aligning standards roadmaps for AM, aiming to achieve one set 
of AM standards to be used all over the world by working in partnership. Perhaps the most 
significant yield from these joint meetings is the establishment of a common structure which 
defines multiple levels and a hierarchy of AM standards as shown in Figure 1 [22].  
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Figure 1 Structure of AM standards. 
3.2 Technology innovations  
3.2.1 Electron Beam Melting (EBM) for stress relieved metal printed parts 
One of the major issues that limit the part quality manufactured through AM processes is the 
build-up of residual stresses in the printed part. Residual stresses are stresses that remain 
inside a material, when it has reached equilibrium with its environment [23]. In most cases, 
residual stresses are unwanted since they result in part deformations. Each production 
process, including conventional subtractive manufacturing process, introduces some degree 
of residual stress. However, the amount of residual stress that is introduced varies 
significantly among different production processes [24]. Taking selective laser melting (SLM) 
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(a form of laser-assisted powder-bed fusion AM, whereby a very thin powder layer is 
distributed and selectively melted by a controlled laser; this procedure is repeated until a 
complete part is built) as an example, this process inherently creates a large thermal 
gradient near the laser spot, giving rise to localised compression and tension, resulting in 
AM parts with significant residual stresses [24]. Additionally, the thermal gradients present 
during the building process are affected by many process parameters (part size, build time, 
powder-bed temperature, melt pool size, etc.). The build-up of residual stresses can 
potentially impact the mechanical performance and structural integrity of AM parts, 
eventually resulting in failure of the AM parts [24]. Effort has been made to understand the 
effect of and coupling between each component in the SLM parameter-set with residual 
stress development, which has in turn prompted the development of process modifications 
aimed to mitigate the problem of residual stress build-up during the fabrication process. In 
most cases, SLM printed parts underwent secondary processing by heat treatment to reduce 
or eliminate the residual stresses [25], consequently increasing the manufacturing cost. An 
innovative solution was presented to enable printing of stress relieved AM parts. This 
derivative of powder-bed fusion AM is known as Electron Beam Melting (EBM). In contrast to 
SLM that utilises laser to melt the substrate, EBM utilises a high power electron beam that 
generates the energy needed to melt the substrate. Additionally, the EBM process takes 
place in vacuum and at high temperatures, resulting in stress-relieved AM parts [26]. 
Although EBM, to a certain extent, can mitigate the issue of residual stresses on AM parts, 
there is still a lack of control and monitoring of the process to ensure better part quality and 
manufacturing repeatability. In order for the industries to adopt these technologies in the 
manufacturing workflow, there is a great need to improve the monitoring, control and 
feedback mechanisms, enabling production of quality assured parts reliably, leading to the 
manufacturing of ready-to-use products. Research effort is currently underway to improve 
the capability of printers to allow real-time monitoring and controlling of the building process 
in a predictive manner, allowing intervention of the build process and spatial adjustment of 
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the printing parameters to ensure compliance is maintained throughout the build process 
[27].  
3.2.2 Multiple-axes 3D printers 
To date, most AM printers utilised a 3-axes (X, Y and Z) positioning system. Recently, 
research efforts have been gear towards development of multiple-axes (> 4 axes) 
positioning system for AM printers to enable added freedom in fabrication of highly complex 
geometrical structure with shape overhangs without the need of support materials. At 
present, multiple-axis AM printer is geared towards metal-based laser-assisted AM printers – 
reaching commercial level [28-30] and fewer for polymer-based AM printers [31-34]. The 
capability of multiple-axes printing for such an AM printer is achieved through the rotation of 
the build platform and/or integration of a robotic arm into the printer hardware setup. The 
potential of a multiple-axis AM printer is enormous, and can enable the true realisation of 
“manufacturing for design” – the unique capability of AM technologies.  
3.2.3 Convergence of subtractive and additive manufacturing 
Although AM technologies offer many advantages over the traditional machining 
manufacturing technologies (subtractive manufacturing), AM does possess manufacturing 
limitations. Amongst these is the need for the AM parts to undergo secondary processing 
such as machine milling, blasting, polishing, etc. to give the product a smooth finished 
appearance as AM-produced parts often have a rough surface [35]. This also means that 
geometrically complex products would need to be printed in multiple parts to enable the 
secondary processing prior to assembling into the final finished product. This in turn leads to 
increased production time and cost. Therefore, it is crucial to integrate both the additive and 
subtractive manufacturing processes, enabling the manufacturing of a finished assembly in 
one streamlined process. Recently, the convergence of additive and subtractive 
manufacturing technology has been realised by a German/Japanese company, DMG MORI, 
enabling the AM of full components in finished parts quality using a single piece of 
machinery. The technology comprised of a laser-deposition-welding head and a 5-axis 
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milling head that is interchangeable during the building process, allowing for the direct 
machining of areas that can no longer be accessed on the finished part. In contrast to DMLS 
which builds parts using laser melting of metal in a powder bed, this technology features a 
metal powder feed system with a deposition rate of up to 1 kg/hour, enabling generation of 
parts 10 times faster than powder-bed AM technology [28]. More recently, Hybrid 
Manufacturing Technologies has presented the AMBITTM multi-task system (patent pending) 
which can be integrated into most existing CNC machines or robotic platforms, enabling 3D 
printing of metal as well as secondary processing (cutting, drilling, marking etc.) just by a 
simple tool change [36].  
3.2.4 Continuous Liquid Interface Production (CLIP) Technology 
For AM to be viable in mass production, print speed needs to be increased by at least an 
order of magnitude while maintaining excellent part accuracy. Carbon3D has recently 
showcased their innovative technology termed Continuous Liquid Interface Production 
(CLIP), which is essentially a modified and refined form of stereolithography. With CLIP, an 
object can be printed continuously due to the presence of an oxygen-permeable window 
below the ultraviolet image projection plane, creating a persistent liquid interface where 
photo-polymerisation is inhibited between the window and the polymerising part. They have 
illustrated that CLIP is capable of reducing part fabrication time while maintaining print 
resolution (< 100 µm) [37].  
4 Additive Biomanufacturing 
4.1 Convergence of Additive Manufacturing and Tissue Engineering & Regenerative 
Medicine (TERM) 
AM has converge into almost all sectors of industries (e.g. aviation, automobile, dental, 
fashion, furniture, implant & prosthetic), gaining market value as the technologies mature 
with continuous research and development (R&D) efforts and standards development., 
Additive biomanufacturing is an upcoming niche within the medical industry, more 
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specifically for the tissue engineering & regenerative medicine (TERM) field. Whereby 
various existing AM technologies were modified and refined to fit its applications and needs. 
In the last decade, AM has emerged as a prominent technology in the TERM field due to its 
ability to create geometrically complex scaffolds customised to each individual patient using 
biodegradable thermoplasts or composites, acting as temporary supporting structures in the 
body to guide tissue regeneration at the defect site (Figure 2 and 3). 
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Figure 2 Examples of scaffolds fabricated via additive manufacturing technologies used in 
large pre-clinical animal models for the evaluation of potential for (A – C) bone and (D – H) 
breast regeneration. (A) Cylindrical medical grade polycaprolactone (mPCL)-based scaffold 
implanted (reproduced with author’s permission [38]) into (B) sheep segmental defect modal 
(reproduced with author’s permission [39]). (C) Three months post-operatively, Bone 
regeneration was more pronounced in recombinant human-bone morphogenetic protein-7 
(rhBMP-7) group compared to scaffold-only and scaffold + mesenchymal stromal cells 
(MSCs) groups. (adapted from [40], Copyright permission obtained from The American 
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Association for the Advancement of Science). (D) Hemisphere-shaped mPCL-scaffold 
implanted subcutaneously into minipigs for a period of six months. (E - H) Haematoxylin and 
Eosin (H&E) staining shows a long-standing regeneration of adipose tissue along with an 
extensive vascularisation within the scaffold pores (adapted from [41]).  
 
Figure 3 Example of scaffolds fabricated via additive manufacturing used clinically for the 
craniofacial reconstruction. (A – C) medical-grade polycaprolactone (mPCL) sheet moulded 
into the required shape by the surgeon prior to implantation. (D) Picture showing the 
implantation of moulded scaffold into a patient with orbital floor fractures. (E and F) X-ray 
images before and after 2.5 years post-surgery, demonstrating complete bone regeneration 
at the defect site (adapted from [42] with copyright permission from John Wiley and Sons).  
However, the regenerative abilities of a scaffold made of thermoplasts or composite are 
limited as thermoplasts lack bioactive factors to cue the regenerative process at the 
damaged sites. Therefore, post-processing is often required to incorporate various types of 
cells and bioactive agents into the scaffold to improve its regenerative capabilities [43]. As 
the field evolved, AM technologies have been adapted, enabling incorporation of bioactive 
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agents into the scaffolds in a one-step fabrication process. This process is often referred to 
as tissue printing, cell printing, biofabrication, biomanufacturing or bioprinting within the 
scientific community. These terms are often used inconsistently or interchangeably, 
underscoring the need for clarifications of terminologies used in this rapidly evolving field as 
recently pointed out by Chhaya et al. [44] and Groll et al. [45]. 
Hence, it is proposed that, for applications of AM in the field of the biomedical sciences, the 
term “Additive Biomanufacturing” is used as an umbrella term to define the various 
technologies utilised for the assembling of tissue engineered medical products (TEMPs) 
layer upon layer.  
4.2 Poly(lactides) as biomaterial in additive biomanufacturing 
The material predominantly used in additive biomanufacturing of TEMPs for the purpose of 
TERM are predominantly biodegradable polymers (either thermoplastic or photopolymeric). 
Among all, poly(lactides) (PLA), its copolymer and composites thereof are commonly utilised 
polymers for the fabrication of scaffolds using additive biomanufacturing techniques [46] to 
aid bone [47-50], cartilage [51] and adipose tissue [44] regeneration. 
4.2.1 Structural composition of PLA 
Poly(lactides) is a thermoplastic aliphatic polyester with a starting compound of lactic acid. 
Due to the presence of a chiral carbon atom, lactic acid exists in two optically active 
stereoisoforms, namely the L (+) and D (-) enantiomers. Cyclization of two molecules of 
lactic acids can give rise to homochiral (D-lactide and L-lactide) or heterochiral lactides 
(meso-lactide) [52] (Figure 4). Racemic lactide (rac-lactide) is an equimolar mixture of D- 
and L-lactides. Using lactic acids or lactides as pre-polymer, PLA can be produced by 
several methods, including direct condensation polymerisation, azeotropic dehydration 
polymerisation or ring-opening polymerisation (ROP) (Figure 4). Very recently, Pretula et. al. 
[52] and Murariu & Dubois [53] have reviewed the methods for synthesising and 
characterisation of PLA and PLA composites, respectively.  
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Figure 4 Polymerisation route for the production of PLA. Modified and adapted from Auras 
et al. [54]. 
Generally, the thermal, mechanical and biodegradation properties of PLA are dependent on 
the choice and distribution of stereoisomers within the polymer chains. For example, melting 
temperature (Tm) of the different lactide stereoisomers are as follows: rac-lactide (122 - 
126°C) > L-lactide = D-lactide (95 - 98°C) > meso-lactide (53 - 54°C) [55]. Depending on the 
choice of pre-polymers and route of synthesis, a vast diversity of PLA (Figure 5) can be 
achieved resulting in PLA with a broad range of physicochemical properties. The optical 
composition of PLA significantly affects crystallisation kinetics and the ultimate extent of 
crystallinity. In turn, the level of crystallinity developed is particularly influential on the PLA 
glass transition temperature (Tg), Tm and the degradation rate [56]. PLA with higher L-isomer 
content has higher optical purity and tends to be semi-crystalline with higher Tm as 
compared to amorphous PLA (lower L-isomer and optical purity) [53, 54, 57].  
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Figure 5 A variety of microstructures of lactides and PLAs. ROP = ring-opening 
polymerisation. Adapted from [55].  
Although derivatives of PLA have been widely fabricated into the form of scaffolds to aid the 
regeneration of tissue, such as bone [58], breast [59], vasculature [60] and nerve [61] or as 
drug carrier [62], most scaffolds were fabricated through conventional techniques (e.g. 
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casting, porogen leaching). As the general trend of TERM field moved towards additive 
biomanufacturing, new compositions of PLA-based biomaterial are constantly under 
development, taking into consideration the specific AM-technologies requirements for 
scaffold fabrication processes. Table 1 shows a list of PLA-based biomaterials which have 
been developed and used for fabrication of scaffolds using AM technologies.  
5 Consideration of PLA as biomaterial in additive biomanufacturing 
The consideration for PLA as material for additive biomanufacturing varies dependent on the 
choice of technology and tissue specific requirements. Hence, scientists have to take into 
account machine-specific limitations and the tissue specific requirements during the design 
of polymer intended for TERM based on AM approaches. The variations of AM technologies 
utilised in the field of TERM have been extensively reviewed by Melchels et al. [63].  
When using PLA-based biomaterials for the fabrication of scaffolds using AM technologies, 
many aspects (e.g. Print material supply, storage, printing conditions, post-processing) have 
to be taken into consideration to ensure that the biomaterial properties are preserved as best 
as possible throughout the scaffold production processes.  
5.1 Print material supply  
Poly(lactides) is a commodity material that have been widely used for making household 
products (i.e. disposable cutlery, cups, plates, personal hygiene products), packaging (i.e. 
food/ cosmetics containers), and medical products (i.e. biodegradable orthopaedic implant, 
sutures, dialysis media etc.). Generally, for biomedical applications, it is essential that 
medical-grade polymers are utilise for the fabrication of scaffolds to avoid harmful leachable 
substances that can cause unwanted adverse reactions. Medical-grade PLA can be 
obtained from various commercial sources, which is distinguished from “commodity grade” 
polymer by a greater degree of purity, extensive in vitro and in vivo testing, manufacturing 
control and regulatory approval. However, due to the stringent requirements in the 
production plant for the synthesis of medical-grade polymer, it is associated with a great 
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difference in cost (i.e. 10 to 50 $/kg for industrial grade and ~ 3000 to 5000 $/kg for medical 
grade). 
In AM, PLA is a commonly used feedstock material in desktop fused filament fabrication-
based 3D printers (i.e. Makerbot, Ultimaker etc.). The relatively cost efficient of these 
desktop fused filament fabrication-based 3D printers and the ease of sourcing PLA filaments 
(non-medical grade) have resulted in its wide adaptations by laboratories within the 
biomaterials and TERM community. This approach is suitable for proof-of-principle studies 
[59, 64, 65], surgical guides and models for preoperative planning as well as for prototypes 
of medical implants [38] (Figure 6). However, it is in large neglected by the scientific 
community that medical-grade PLA must be used for any research which aims towards 
clinical translation of scaffolds, hydrogels and implants.  
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Figure 6 Biomedical applications of non-medical and medical grade poly(lactides) 
dependent on the end-use. (a to c) showed the applicability of AM technologies in the 
biomedical engineering field. (a) Illustrated a hip implant prototype made of poly(D,L-lactic 
acid)(PDLLA) [38]. (b) Showed a PDLLA scaffolds used for proof-of-principle study for its’ 
potential in adipose tissue regeneration [59]. (c) Showed a custom-made rat bed for animal 
restrain during magnetic resonance imaging, demonstrating that PLA can be use for the 
manufacturing of low-cost laboratory consumables using AM technologies [66]. (d) Showed 
the ABSORB BVSTM scaffold [67] and orthopaedic screws and plate [68] made of medical-
grade PLA using conventional manufacturing technologies for clinical applications. 
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In the field of additive biomanufacturing, most PLA-based biomaterials (listed in Table 1) are 
still at the R&D phase. Hence, the polymer was synthesised in batches in relatively small 
scale. Inevitably, there exists batch-to-bath variations (i.e. chemical purity) during the 
production process. Consequently, this may affect the downstream processes and ultimately 
influence the scaffold properties (i.e. degradation rate, mechanical properties). For example, 
the presence of non-polymeric content (i.e. metal catalyst residual) compromises the thermal 
stability of PLA [69-71], resulting in compromised processability using melt-based extrusion 
process [72, 73]. Hence, in this case, implementation of Good Laboratory Practice (GLP) 
alongside with characterisation of each batch of the synthesised polymer in term of chemical 
purity, molecular weight, structure and physical properties are necessary to ensure 
consistency across the different batches of synthesised polymer.   Hence, for the production 
of PLA-based TEMPs using AM technologies, bioengineers would have to consider the 
supply chain of the raw material (batch to batch variation) to ensure minimal variation in the 
end product. 
5.2 Storage conditions 
It is known that PLA has the ability to absorb moisture for the atmosphere, resulting in the 
hydrolysis and cleavage of the ester linkages [74]. Therefore, to minimise the risk of 
molecular degradation, it is necessary that the storage conditions are highly controlled. 
Ideally, PLA-based materials should not be exposed to atmospheric conditions, thus, 
packages should be kept sealed until ready to use. If not entirely used, it should be promptly 
dried and resealed. In the case of photopolymer (i.e. PLA formulated for stereolithography), 
the material should be kept in the dark to prevent crosslinking of reactive groups in the 
polymer chain.  
Similarly, upon the completion of the fabrication process, scaffolds should be packaged and 
stored appropriately, for example, the scaffolds can be packaged using moisture-resistance 
foil liners and/or in an inert gas atmosphere until further use.  
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5.3 Printing conditions 
For the fabrication of scaffolds using AM technologies, the crucial parameters include the (a) 
processing temperature, (b) residence time in melt and (c) ambient conditions.  
In the fabrication of scaffold using PLA-based biomaterials, one major problem is the limited 
thermal stability of PLA during the melt processing. The ester linkages of PLA tend to 
degrade into smaller fractions when exposed to heat and the degradation rate rapidly 
increases above the melting temperature. A study by Taubner and Shishoo on the influence 
of melt extrusion processing parameters on poly(L-lactic acid) (PLLA) (Tm: 180 to 250°C) 
demonstrated that the processing temperature must be kept at a low level to minimise 
polymer thermal degradation. At the processing temperature of 210°C, the loss in Mn 
(number average molecular weight) was less dependent on the residence time in melt 
compared to when processed at 240°C. Additionally, it was found that presence of moisture 
in the material contributes further to the degradation process [75].    
Since the introduction of AM technologies, PLA has been used as building material, 
especially for melt-extrusion based 3D printers with a filament feeder system (e.g. Makerbot, 
Ultimaker, etc.) due to its good thermoplastic properties, which results in good printability. 
However, in a filament feeder system, users are limited in terms of material flexibility, 
whereby a given material needs to be fabricated into the form of filaments prior to the 
fabrication process. Additionally, the filaments need to be relatively strong to prevent 
filament slipping during the fabrication process. Hence, other forms of melt-extrusion based 
3D printers (illustrated in Table 2) have been developed with significant improvements in 
terms of material flexibility. Besides that, materials can be used in the form as it was 
synthesised, avoiding any pre-processing of polymer prior to the scaffold fabrication process. 
However, one down side of the non-filament feeder system is that material is kept at the 
molten stage for an extended period. This is a major limiting factor for PLA-based 
biomaterials, as it has been previously shown that increased melt resident time of PLA 
increases the thermal degradation rate [75].    
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During the scaffold fabrication process, the ambient processing conditions should be tightly 
regulated. Liu et al. [76] and Rasselet et al. [77] have reported that the degradation of 
poly(D,L-lactic acid) (PDLLA) in its molten form proceeds in a random chain scission 
mechanism and the presence of oxygen has a promoting effect on the thermal oxidation of 
PDLLA. Hence, Polymer processing of hydrolytically and/or oxidatively- sensitive polymers 
(i.e. PLAs) by extrusion or injection moulding is typically performed under inert gas (e.g. 
argon, carbon dioxide, nitrogen) to prevent extensive degradation [78]. Therefore, a future 
printer design that would allow fabrication of scaffolds made of PLA-based biomaterials 
under an inert gas atmosphere would be a significant improvement. 
5.4 Sterilisation 
All scaffolds will need to be sterilised, whether for in vitro or in vivo experiments or surgical 
implantation to reduce the risk of infections. This can be achieved through various 
sterilisation methods, including but not limited to ethylene oxide, radiation (i.e. gamma, 
ultraviolet), steam and ethanol. PLA-based scaffolds, in addition to being susceptible to 
degradation by moisture and radiation, are heat sensitive because of their thermoplastic 
nature. Thus, the selection of a suitable sterilisation technique for PLA-based scaffolds is 
crucial to their physical and mechanical properties, and hence to their overall tissue 
regeneration performance.  
Sterilisation using 70% (v/v) ethanol has been widely used in laboratory settings as it is 
readily available in almost all laboratories with cell culture facilities and the ease of use. 
However, at concentrations of 60 to 80% (v/v), ethanol is classified as a disinfectant rather 
than a sterilisation agent because of its inability to destroy hydrophilic viruses or bacteria 
spores [79]. Hence, although it has demonstrated apparent effectiveness in preventing 
infection in cell culture experiments and has minimal effect on scaffold’s morphological 
characteristic [80], it cannot be use for in vivo applications of biomedical devices.  
Steam sterilisation techniques commonly involve high moisture and temperature in excess of 
100°C. Such temperature can approach or exceed the thermal transition temperature of 
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PLA-based scaffolds, consequently altering the physical and mechanical properties. It was 
previously shown that steam sterilisation of PLLA induces a significant change in the 
polymer molecular weight, which would affect the degradation kinetics of the polymer [81].  
Sterilisation by gamma (γ) or ultraviolet (UV) radiation may be used for the sterilisation of 
PLA-based scaffold. However, one must be careful on the radiation dosage and duration to 
avoid non-reversible damage. This is because radiation can initiate polymer crosslinking or 
breakage of polymer chains leading to substantial change to the polymer properties [82].   
Chemical sterilisation by ethylene oxide (EO) is often used for polymers that are sensitive to 
heat and moisture. This is particularly true for PLA-based scaffolds. However, harmful 
quantities of EO residues may be trapped within the scaffolds volume resulting in non-
biocompatibility. The amount of gas absorbed into the polymer is dependent on the 
equilibrium absorption and diffusion coefficient, which differs dependent on the polymer 
compositions and sterilisation parameters [82]. Hence, it is crucial that PLA-based scaffolds 
are subjected to adequate degassing or aeration subsequent to EO sterilisation to eliminate 
the residual EO [83].   
Various studies have demonstrated that sterilisation of PLA-based biomaterials, regardless 
of the sterilisation method, to some extent inflicted structural or molecular changes and 
consequently altered the material properties (i.e. mechanical properties, degradation rate) 
[80-82, 84, 85]. Hence, the sterilisation method should be adjusted dependent on the 
polymer composition such that the resultant effects are favourable and not detrimental to the 
end-use. 
6 Challenges for Additive Biomanufacturing 
Although AM technology has come a long way since its first introduction in the TERM field, 
there are still many challenges which need to be addressed to establish a new gold standard 
for the design, optimisation and fabrication of a tissue-engineered construct (TEC) while 
ensuring functionality. This is because the complexity of the human body has added another 
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dimension of challenges in adaptation of AM in the TERM field as bioengineers not only 
have to consider the biophysical and manufacturing requirements, yet also the biological 
requirements to ensure functionality of the fabricated TEC. To achieve complete adaptation 
of AM processes in the TERM field, the TEC must be fabricated rapidly, efficiently and 
consistently while meeting all stringent functional requirements and FDA safety-compliances. 
The major challenges in additive biomanufacturing are shown in Figure 7.  
 
Figure 7 Challenges for additive biomanufacturing. 
6.1 Biomaterials 
Among the selection of characterised materials commercially available for the different AM 
technology platforms, from polymers to ceramics to metals, there is only a limited subset that 
is suitable for TERM applications. This is because the requirements differ from other 
industries’ requirements as the materials are anticipated to be in direct contact with human 
tissue for extended periods of time. The materials have to be (1) biocompatible, whereby it 
evokes host responses appropriate in a specific application with minimal non-specific activity; 
(2) bioresorbable, where the degradation rate is proportional to the regenerating rate of the 
target tissues/organ, and (3) can withstand medical sterilisation procedures to prevent 
infection. Moreover, to enable AM driven TERM, biomaterials have to be printable. Over the 
past two decades, although tremendous efforts have been invested in synthesising and 
characterising biodegradable materials- including polymers (natural and synthetic) [86], 
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bioceramics [87], bioactive glass [88] and composites [89, 90] that are suitable for TERM 
applications, only a selected few are suitable for AM processes.  
Polymers are ubiquitously used across the different AM technologies as they can be 
synthetically synthesised and modified to suit the requirements of different AM processes. 
Polymers currently used in additive biomanufacturing can be loosely classified into 
thermoplastics and photopolymers. Thermoplastics are commonly used in filament/melt-
based extrusion and powder-based fusion AM technology segments, whilst photopolymers 
are usually used in optical fabrication processes. These polymers have all, with a few 
exceptions, been modified or synthesised specifically for use with a particular AM technique, 
enabling fabrication of scaffolds with well-defined architectures with predictable 
physicochemical properties. While these scaffolds could act as temporary support for cell 
attachment, migration and growth, they are not conducive for direct inclusion of cells during 
the printing processes. While there are several AM technology platforms (e.g. extrusion 
printing, microvalve printing, inkjet printing and laser-assisted printing) that can be utilised for 
bioprinting, there is a lack of suitable biodegradable polymer that fulfils the bioprinting, 
physiochemical as well as biological requirements. Melchels et al. [91] have developed a 
new form of biomaterial, the so called “bioink”, in the form of a hydrogel (gelatin-
methacrylamide-gellan gum) that can form high fidelity cell-encapsulated matrix using AM 
processes while not compromising cell viability.  
Despite the effort in developing new polymers for additive biomanufacturing, the TERM 
community faces the same challenges as other industries, whereby the use of polymers for 
mass production of consumer products by AM processes is prevented due to the lack of 
confidence by the manufacturer for the reliable reproduction of quality assured end products. 
This is due to a knowledge gap in the effect of AM building process on the thermal, optical 
and rheological properties of a given polymer, which can subsequently impact on the product 
performance, e.g. mechanical behaviour. Despite these drawbacks, polymer-based printers 
have successfully penetrated the consumer market due to their relatively lower cost 
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compared to metal-based printers, whereby hobbyists can purchase a plastic-based printer 
at $600 and raw material can be obtained for as low as $30 per kg.  
In powder-based fusion printers, it is well established that during the fabrication process the 
polymer has to be maintained in the metastable thermodynamic region (between the melting 
and crystallisation temperature). However, the optimal metastable thermodynamic region for 
most polymers is still not clearly defined; moreover, during the building process, the 
temperature is hardly controllable. This may induce premature crystallisation of the polymer 
(a non-visible defect), compromising the mechanical properties of printed parts [92]. 
Additionally, polymers may also experience shrinkage during the AM processes, resulting in 
a deviation of the final dimensions of the printed part compared to the original design. This 
can be partly overcome by using higher molecular weight polymers, but can lead to difficulty 
in the printing process because of the high viscosity involved [93]. Another consideration 
when using polymers in AM processes is their thermal degradation over time, which can in 
turn influence the polymer molecular weight and the AM-printed part quality. Thus an 
optimum polymer molecular weight range does exist for AM processes, but it is not easily 
controllable [93]. Moreover, in bioprinting, inclusion of bioactive agents or cells during the 
printing process may also influence the biomaterial properties which needs to be identified 
and characterised to ensure no detrimental effects to the biomaterial properties.   
Currently, there is an array of biocompatible and bioresorbable materials that can be utilised 
for production of TE products using AM technologies and scientists are continuously 
developing new biomaterials. Despite all the newly developed AM-printable biocompatible & 
biodegradable biomaterials, there is a lack of databases on mechanical properties of AM-
fabricated parts and the interaction between materials and process parameters. In 
metallurgy, it takes about 10 years to develop a new alloy, including the determination of 
various critical properties such as fatigue strength. This time frame also applies to 
developing new materials for additive biomanufacturing, which have different requirements 
dependent on the target tissue to be regenerated.  
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6.2 Computer-Aided Design, Engineering and Manufacturing  
In TERM, scaffold design, modelling and manufacturing are crucial steps as the internal 
architecture greatly influences key factors for tissue regeneration, such as nutrients diffusion, 
cell adhesion and matrix deposition. Additionally, the degradation rate and the mechanical 
properties of the scaffold vary dependent on the scaffold internal architecture. Therefore, 
scaffolds intended for TERM applications have to be carefully designed, keeping in mind the 
case-specific mechanical, mass transport and biological requirements. However, designing a 
scaffold that fulfils such conflicting requirements, such as the biological and mechanical ones, 
still remains a challenging issue.   
If AM is employed to overcome these complex design challenges, it becomes important to 
not only identify the specific manufacturing capabilities of AM, but also the technological 
challenges. Although these capabilities and constraints vary depending upon the AM 
process being used, there is one manufacturing constraint common to all extrusion-based 
AM processes. The deposition nozzle must remain normal to the build surface. This results 
into accessibility constraints as collisions with the part being printed must be avoided at all 
costs. Moreover, this limitation also prevents the fabrication of highly complex free-form 
structures without the use of sacrificial support structures.  
In order for the fabrication of scaffolds/TECs, first, a digital representation of the scaffold/ 
TEC has to be established. Figure 8 shows a digital product development workflow that 
could be adapted for additive biomanufacturing.  
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Figure 8 Digital product development workflow. 
Generally, the acquisition of 3D models from 2D clinical scan data is a well-established 
method that can be achieved using specific computer software (i.e. InVesalius or Mimics), 
resulting in the growing clinical use of customised metallic implants [18, 94]. Detailed 
methodology for the conversion of 2D clinical scans data to 3D model using InVesalius 
(open-source) is presented by Jardini et al. [18].  
6.2.1 Computer aided design (CAD) 
Currently, there are 2 major classes of CAD tools– Parametric Modelling and Boundary 
representation (B-rep) modelling. Parametric modelling (e.g. Solidworks and Autodesk 
Inventor) use parameters such as model dimensions, features and material density to 
describe a 3D model [95]. Such parameters can be modified later, which causes the entire 
model to be updated automatically. In such software, features describe a part, while an 
assembly is described by a collection of parts. On the other hand, B-rep modelling (e.g. 
Rhino3D) generally represents solid models as a watertight shell of zero-thickness surfaces 
[96]. If the model is not watertight, the software has difficulty in distinguishing the ‘inside’ of 
the solid model from the ‘outside’.  
While both these approaches are elegant methods to represent conventional products or 
components, they do not allow for fabrication of complex lattice-based networks that can 
typically be manufactured using AM. A single strut in a lattice-network may easily be 
represented as a small extruded feature (parametric) or a few surfaces (B-rep), but even a 
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moderately sized lattice structure composed of thousands of such struts becomes so 
computationally demanding that it renders the use of such approaches unfeasible. Especially 
in case of B-rep software, such a large number of struts increases the probability of non-
manifold errors occurring (e.g. gaps between polygons or self-intersecting structures) which 
compromise the watertight boundary. Therefore, in additive biomanufacturing, parametric or 
B-rep modelling can be useful in setting the overall-shaped (macro-architecture) of the 
scaffold/TECs, but may limit the design of the scaffold internal geometry (micro-architecture), 
which is crucial for determining the scaffold/TECs mechanical and mass transport 
capabilities and ultimately the tissue regeneration capability.  
Generative design methods, whereby a design is generated by a set of rules or an algorithm, 
are commonly used in the fields of sound engineering, animation, communication design and 
architectural modelling [97]. Natural design processes such as through genetic mutations 
and crossovers can also inspire such generative designs by using a genetic algorithm [98, 
99]. Often, building on the parametric or B-rep modelling concepts, generative design 
transforms the computer from a modelling assistant to a generator through the use of a 
defined set of rules or an algorithm. Making small modifications in the values fed into these 
equations radically alter the entire geometry of the 3D model, allowing for rapid generation of 
an entire family of designs, which can be tested either computationally or mechanically to 
choose the optimum design candidate. Indeed, the last few years have seen the emergence 
of a multitude of scripting and modelling tools that allow for Generative Design approaches 
(e.g. Grasshopper Plugin for Rhino3D, Processing, Quartz Composer etc.). Although, such 
software have made it relatively easy for non-programmers to implement their ideas, a 
Generative Design-based CAD modelling software, specifically designed for complex 
additive biomanufacturing remains elusive. Indeed, in the field of additive biomanufacturing, 
generative design methods have been adapted [100, 101] to enable better control over the 
micro-architecture design of a scaffold and/or a TEC. However, the implementations of 
generative design method in CAD modeller software for generation of the scaffolds’ internal 
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micro-architecture require high computational power. Additionally, fitting a series of unit cells 
along an anatomical-shaped contour can be mathematically challenging and exponentially 
increase the computational power require. Therefore, repeating unit cells that made up the 
micro-architecture of a scaffold is usually “filled” into the overall scaffold’s macro-architecture 
using Boolean operations, producing a scaffold CAD model with the desired micro-
architecture [102-106].  
Another shortcoming of current CAD tools is the lack of integration with interactive design 
tools that can help designers to visually conceptualise the design in an environment closely 
mimicking the real world situation. Interactive design tools such as augmented reality (AR) 
and virtual reality (VR) can greatly enhance the human-computer interface in product design 
[107, 108]. Currently, in the medical sector, such AR and VR technologies are being 
explored for simulation-based medical education [109] and as aid for surgeons in pre-
operative planning [110, 111]. In the context of additive biomanufacturing, AR and VR can 
aid in the scaffold design process, whereby bioengineers with the minimal knowledge on the 
human anatomy can superimpose the scaffold CAD model to an anatomical relevant site 
(defect site) thus helping bioengineers in visualising the practicality of the scaffold overall 
geometric design in a real world application.  
6.2.2 Computer Aided Engineering (CAE)  
For the past decades, “trial-and-error” approaches have been used to study different scaffold 
architectures by conducting in vitro and in vivo experiments. The cost (labour, time, money) 
involved in this approach is rather inefficient, thereby driving the field towards adaptation of 
computer aided engineering (CAE) into the scaffolds/TECs manufacturing workflow to 
enable optimisation of the scaffold design in silico, identifying the most suitable configuration 
of scaffolds for the replacement of a desired tissue.   
Among the in silico strategies, finite element analysis (FEA) has enabled the simulation of 
the mechanical behaviour of a given scaffold design. Using the simulation result, 
bioengineers and scientists can make changes to the scaffold design to achieve a scaffold 
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with the required mechanical properties. Currently, FEA can be done using the scaffold CAD 
model or a 3D model obtained from microCT reconstruction of additively manufactured 
scaffolds. Several studies have demonstrated that the theoretical prediction of the porous 
scaffold mechanical behaviour using the CAD-based approach is comparable to the 
experimental results [100, 112, 113]. Despite this, there is still a standing debate in the 
accuracy of CAD-based modelling due to the discrepancies between the intended design 
and the final shapes of the additively manufactured objects. These discrepancies arise 
during the fabrication process. They include unplanned surface roughness, micropores, 
residual stresses and etc. - which are still poorly understood [114]. As a consequence, some 
have opted for the scaffold 3D model obtained from microCT-reconstruction for simulation of 
the scaffold mechanical behaviour [115, 116]. 
Another consideration from a design point of view is the mass transport properties of the 
scaffolds. Bioengineers aim to compute and model the effective diffusivity of a given scaffold 
design as illustrated by Jung et al. [117]. However, the prediction of the scaffold permeability 
is not adequate, as it does not take into consideration the fluid dynamics within and around 
the scaffold. For example, when culturing cells on large-sized scaffold and/or TECs, 
bioreactors are needed to aid the perfusion of media (nutrients and waste) through the core 
of the scaffold and/or TECs to ensure cell viability. Consequently, this could create a 
gradient of shear rate throughout the scaffold length that could positively or negatively 
impact the cells’ behaviour. To account for the dynamic fluid movement around and within 
the scaffold, computational fluid dynamics (CFD) has been applied to study the shear stress 
distribution across the scaffold [118-120]. However, to date, only a few studies have 
succeeded to perform a correlation between CFD results and scaffold internal architecture 
[121] or cell behaviour [122]. 
Computation simulation in the field of TERM is slowly moving towards the integration of 
scaffold performance over time during the tissue regeneration processes, which can be 2 to 
3 months in the case of skin regeneration and 6 to 9 months in the case of bone 
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regeneration [123-125]. With the simulated result, one can optimise the design to obtain an 
optimal scaffold architecture corresponding to the tissue regeneration rate. Since the effect 
of vascular supply also plays a crucial role in tissue regeneration, a computational model 
based on mechanical environment and local vascularity has also been developed [126] and 
there are a number of approaches to integrate the engineering of perfusable vascular 
networks inside the TEC to improve the early connection to the circulation [127]. 
Although various simulation models have been established for validation of the scaffold 
capabilities in silico, most of the proposed models have not been validated with experimental 
results. This is most likely due to the limiting factor such as printer availability and printability 
of the proposed scaffold design. To enable adaptation of a specific simulation model into the 
scaffold/TECs design workflow, the simulation model has to be validated with extensive in 
vitro and in vivo experiments to ensure the theoretical assumptions of the model correlate 
well with the physiological conditions.  
As previously mentioned, conflicting requirements have to be simultaneously addressed in 
the design of scaffold and/or TECs, e.g. high porosity is preferable for increased mass 
transport, yet, as porosity increased, the scaffolds’ mechanical properties lowered. To 
overcome this challenge, design strategies capable of finding the optimal trade-off between 
these two opposite requirements has been proposed by Hollister’s group [128-130] and 
Almeida & Bartolo [131]. Going beyond the computational prediction of scaffold properties 
(mechanical and mass transport), they have combined in silico modelling with topological 
optimisation to enable better automation of the design process by taking into account the 
functional requirements. With their approach, the design process is partially automated, 
whereby the unit cell/architecture is introduced into the scaffold to attain the desired 
properties based on the given constraints. 
6.2.3 Computer Aided Manufacturing (CAM) 
The use of computer systems in a non-design activity but in the manufacturing process is 
called computer aided manufacturing (CAM) [132]. Typically, a CAM system acts as an 
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interface between CAD and the manufacturing machine. The complex drawing created by 
CAD tools is “translated” into code of letters, numbers and special characters (e.g. G-code) 
that is recognisable by the machine. As the digital technologies evolve rapidly, todays’ CAM 
systems utilised by conventional subtractive machining-based manufacturing industries are 
capable of planning, scheduling, monitoring, decision-making and generally managing all the 
aspects of the manufacturing procedure, even “think” and adapt to changes automatically. 
This advanced CAM system capability is yet to be integrated into the AM-based 
manufacturing lifecycle.  
The inherent complex interaction of the AM process parameters (e.g. stage and print head 
travel speed, translation path, material feed rate, pressure, temperature, laser power etc.) 
and the resultant physical phenomena (e.g. melting/solidification of material, heat and mass 
transfer, moving heat source etc.) complicates the development of process-property 
relationships and appropriate process control. Thus, an effective in-process simulation 
model will be very useful for pre-assessing the impact of process parameters and predicting 
optimised process conditions. It can decrease the need for real world testing of technologies 
and processes and give product designers a predictive capability. Models are also the basis 
for developing the required control technologies (hardware and software) for AM production 
processes. They will also provide support for standards developments as qualification & 
certification methods [133]. For the development of an accurate in-process simulation model, 
comprehensive and validated data on materials and processes are mandatory, as well as an 
excellent understanding of the fundamental processes and physical phenomena that 
underlay AM feedstock inputs, approaches, and technologies.  
The adoption of AM in the aviation and automotive industry has pushed for development of 
in-process simulation models to achieve an optimised trade-off between fast processing time, 
and relatively stress-free structures with good microstructural and mechanical integrity. As 
the aviation and automotive industry predominantly uses powder-fusion based AM 
technology, most of the simulation models are performed for the printing of metallic parts. 
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Currently, various process and material models have been proposed, addressing 
phenomena such as heat transfer [134], melting/solidification phase change [134, 135], free-
surface flow [135], and residual stresses [136, 137], which are closely related to the 
mechanical properties of the final AM printed-part. Martukanitz et al. [138] has described the 
AM process for metallic materials by integrating two computational simulation modules using 
an “uncoupled” approach, which allows each submodule to be independently developed (as 
long as a consistent data exchange format and consistent units and scaling are used). Such 
an approach can be intertwined with the existing workflow of fabricating AM products, 
starting from the commonly performed CAD model slicing technique to generate the layer 
geometries. Martukanitz’s model proposes using the motion of the extruder head (or laser 
source in case of Direct Metal Laser Sintering) as the primary heat source and mapping the 
motion of the extruder head to perform the thermo-mechanical simulation of the rapidly 
changing conditions within the AM machine. The output file of such an operation will include, 
in addition to the movement coordinates of the extruder head, time, temperature, 
displacement and stress for each computational node/element within the model. This 
exported file, referred as “TTSP” (time, temperature and stress at position) can be fed 
directly into another microstructural simulation submodule, which tracks the evolution of the 
plastic/metal microstructure at positions of interest within the build. The authors also propose 
sophisticated Process Models and Material Models. However, discussions of these fall 
beyond the scope of this report. Interested readers are advised to refer to the original source 
[138] for further information.  
Despite the efforts in developing an accurate simulation model for the entire AM fabrication 
process, most existing models lacks the capabilities to couple AM design, materials selection 
and manufacturing processes. It is of desire for the development of dynamic and “intelligent” 
simulation models that can obtain in situ measurements during the AM building process, 
predicting structure properties and detecting potential structural defects, which in turn 
provides real-time feedback for process control. In order for the realisation of such a 
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dynamic model, it is crucial to develop a technology that can enable accurate and reliable in-
process measurements and non-destructive inspection methods. Moreover, to better support 
effective development of modelling and simulation tools for AM processes, standards needs 
to be established to support consistent data input due to the diversity of AM equipment and 
process types.  
6.2.4 CAD/CAE/CAM digital data management 
At this point, it becomes important to discuss the file format that allows the digital exchange 
of information among CAD, CAE and CAM systems. The first-ever vendor neutral standard 
on computer graphics exchange was the Initial Graphics Exchange Specification (IGES), 
championed by the United States Air Force (USAF) Integrated Computer-Aided 
Manufacturing (ICAM) project to integrate all operations in Aerospace manufacturing in order 
to close the gap between parts design and manufacturing. A serious issue, at the time, was 
the incompatibility of the data produced by the CAD software with the Numerically Controlled 
(NC) machine tools used to manufacture the parts. IGES solved this problem by introducing 
a common file format through which two seemingly disparate computer systems could 
communicate with each other. IGES has since been replaced with ISO 10303 Standards for 
the Exchange of Product (STEP) model data. Whereas IGES was developed primarily for 
the exchange of pure geometric data between CAD and NC machine, STEP is intended to 
handle a much wider range of product-related data covering the entire life-cycle of a product 
[139]. Although the STEP standard has been in continuous development since 1984 as a 
successor to IGES, it has mainly been designed to work with specific CAD software 
(parametric and B-rep) and CAE software. Consequently, it does not adequately support 
complex 3D surfaces, materials, lattices and tessellation that are hallmark features of the 
additive biomanufacturing technology. Furthermore, modern AM machines also do not 
natively support slicing of STEP files into machine toolpaths. On the other hand, the newly 
emergent Additive Manufacturing File Format (AMF) (ISO/ASTM 52915:2013 standard [140]) 
does contain all of these features. However, it is not compatible with complex CAE modelling 
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systems such as ANSYS, Abaqus, Hypermesh etc. The authors therefore advocate a 
merging of STEP and AMF standards to create a standard file format appropriate for the 
entire workflow of AM-based CAD to CAE to CAM.   
Throughout the digital product development workflow, computational simulation plays a 
major role, from CAD to CAE to CAM. A recent review by Mourtzis et al. [108] gives a good 
overview of the various simulation methods and tools to product and production lifecycles. 
Among which augmented reality (AR) and virtual reality (VR) technologies seem to be an 
interesting avenue that is yet to be explored in the additive biomanufacturing field.  
6.3 AM and Additive biomanufacturing Hardware 
Over the years, scaffold-based TERM approaches have evolved into three general trends: 
scaffold fabrication, cell printing or a combination of both. As opposed to scaffolds fabrication, 
cell printing involves additional complexities, such as the choice of cell types, growth factors, 
and the sensitivities of cell or growth factors to the fabrication process. 
The current trend in the field is a multiphasic scaffold design which is based on the 
accumulated knowledge from studying the relevant scaffold literature and implementing the 
key design parameters into the built of an architecture and morphology, which allows cell 
migration, proliferation and subsequently vascularized tissue formation. 
6.3.1 Manufacturing tools 
After over two decades of intense R&D in the field of AM technologies, it can be concluded 
that the hardware design of most AM printers has reached a certain maturity. Additive 
biomanufacturing of scaffolds can be achieved through the various AM technology segments, 
each with their respective pros and cons. These have been extensively described and 
discussed in the review articles by Murphy and Atala [141], Melchels et al. [63], Mota et al. 
[142], and Bártolo et al. [143]. Dependent on the availability of the desired biomaterials and 
the intended application, one particular AM system may be better than the others. From the 
perspective of additive biomanufacturing on a research scale, one major disadvantage of 
 
41 
 
most commercial AM printers is the lack of flexibility in adapting for variety of biomaterials 
(i.e. new formulation of polymer as candidate biomaterials). Moreover, most AM printers 
require a relatively large quantity of biomaterial to be loaded on the printers’ feeder/material 
chamber in a specific form (filament, powder or photo-crosslinkable solution) to enable 
scaffold fabrication. During the fabrication process, biomaterials may undergo thermal or 
oxidative degradation; therefore, reusing of the biomaterial is not permitted as it may have 
detrimental effects on the scaffold quality and performance, leading to unnecessary wastage 
of expensive or rare biomaterials. Therefore, existing AM printers are being modified to 
facilitate also additive biomanufacturing. For example, instead of a filament feeding system, 
feeding system using a syringe-like design [144] or ink jet methodology [145, 146]. Such 
feeding systems allows for fabrication of scaffolds with relative freedom of choice of the 
biomaterials to be used. Additionally, the estimated necessary volume of the biomaterial can 
be loaded into the feeder, eradicating biomaterial wastage in large.  
In terms of cell printing, the main technologies used are inkjet, microextrusion and laser-
assisted printing systems, which have been described by Murphy and Atala [141]. When 
designing parts for a cell printing, engineers have to take into consideration the biological 
requirements, whereby the environment has to be precisely controlled under up-to-date 
Good Manufacturing Practices (i.e. temperature, humidity and sterility). As an example, 
temperature has to be maintained at physiological temperature to minimise the risk of cell 
death during the fabrication process, since any temperature fluctuation may have detrimental 
effects on the cell viability.  
During the construction of scaffold/cell constructs, spatial distribution of cells and 
biomolecules across the architecture is crucial to better mimic the complex structure of 
tissues and organs, which consist of multiple types of cells with distinct hierarchical 
arrangement. Various research groups have proven the capabilities of bioprinters to deliver 
constructs with defined placement of cells and biomaterials [147-149]. Although bioprinters 
theoretically permit the printing of complex, multi-material biological constructs, there is one 
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common downfall across all the bioprinters - the print speed. In bioprinting, time is crucial, as 
prolonged printing time may exponentially increase the risk of cell death. Thus, to date, cell 
printing is still limited to fabrication of constructs with relatively small dimensions. Therefore, 
to further advance bioprinting, innovative solutions in terms of hardware design are 
necessary. One obvious way to further advance cell printing is to significantly improve the 
print speed while not compromising the resolution. Alternatively, engineers have to come up 
with innovative hardware design solutions that converge bioprinting with bioreactor 
technologies to enable printing of large size constructs while maintaining the nutrients and 
waste transport across the architecture to ensure cell survival through the prolonged 
fabrication period.  
6.3.2 In-process monitoring tools 
The AM machine itself and the process variability during the fabrication process can 
negatively impact the quality of the printed part. This means that qualification and 
certification are significant challenges for widespread adoption of AM. Recently, numerous 
industry reports have called for real-time, close-loop process controls and sensor to ensure 
quality, consistency and reproducibility across AM machines [150]. The overall goal is to 
achieve a robust layer-by-layer quality assessment that will eliminate post-build inspection –
achieving a state of certify-as-you-build with AM technologies. At present, the development 
of in-process monitoring tools is emphasising on temperature monitoring with dominant 
focus on metal-based additive manufacturing [151-153]. Pyrometers and thermocouples are 
generally used for temperature monitoring. Pyrometer is a broad term describing contactless 
sensor devices that measure temperature of a body based upon its emitted thermal radiation 
(e.g. photodetectors, digital cameras with charged-coupled device or complementary metal-
oxide semiconductor technologies) [151]. On the other hand, thermocouples take contact 
temperature measurement. Thermocouple consists of two wires connected together at one 
end with a voltage measurement device connected across the free-ends. The working 
principle is that electric current flows in a closed loop of two dissimilar metals when their 
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junctions are at two different temperatures. Hence, when the connected junction (point of 
contact for measurement) is at a specific temperature, a voltage difference (or electromotive 
force) dependent on the temperature at the joint is created between the free ends of the 
wires [154]. The respective advantages and disadvantages for use of pyrometer and 
thermocouple for temperature measurement are listed in Table 3. 
Beside temperature measurement, a pyrometer device equipped with CCD-based digital 
camera has also been used for monitoring layer height during the AM process [155-157]. 
Another form of sensor use for monitoring layer height during the AM fabrication process is 
the displacement sensor (also commonly known as distance or proximity sensor) [158, 159], 
a device that detects presence of objects without physical contact. It consists of two parts: a 
transmitter that sends a laser signal and a receiver that collects this signal. Its operating 
principle is measuring the time it takes the signal to be sent, hit the monitored surface, and 
return to the receiver. Next, it translates this into a distance between the sensor and the 
surface it is intended to measure [151].  
To date, almost all research efforts in developing in-process monitoring tools are focused on 
simple geometries, which overrides one of the most powerful aspects of AM – the freedom of 
design geometries. Thus, more R&D needs to be planned and executed towards monitoring 
and control of geometrically complex structure, i.e. lattice structure- that is predominant in 
TERM applications. To date, very few research groups have looked into relatively more 
complex geometries for in-process monitoring and control [160, 161]. Moreover, there is a 
lack of R&D effort in developing in process monitoring and control for polymer-based AM 
technologies.  
6.4 Systems integration  
Systems integration, when introduced into the AM industry has the potential to replicate 
physical transformation process with standardised computer models and simulations – 
reducing cost, ensuring material quality, dimensional attributes, developing process metrics 
and product acceptance [138, 162]. Indeed, creation of a part by means of AM is quite 
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intricate, during the AM process, different sub-processes are necessary and the boundaries 
that define these sub-processes may differ depending on the perspective taken. Moreover, 
fabrication of scaffold and/or TEC intended for TERM added another dimension of 
considerations. Therefore, to enable production of scaffold and/or TEC by mean of additive 
biomanufacturing, the sub-processes must be well integrated in order to fulfil the scaffold 
and/or TECs performance requirements.   
Witherell’s group at the National Institute of Standards and Technology has identified six key 
areas for the development of information system architecture tailored for AM [163], including 
(1) “Design information- design intent, design rationale, material selection and performance 
requirements/constraints”, (2) “Geometry information- the preservation of shape and features 
(including GD&T) during design-to-product transformations”, (3) “Process information- how in 
situ measurements can be fed back into the digital thread for validation and verification”, (4) 
“Material information- the role of material information and material properties in an overall 
AM systems architecture”, (5) “ Traceability- the information requirements necessary to verify 
and validate an AM part throughout design-to-product transformations” and (6) “Disruptive 
technologies- the information challenges/ opportunities in developing technologies, including 
topological optimization and part regeneration”. The efforts by the group also support the 
information requirements for verification and validation techniques, complementing design 
rules currently covered under ASTM F42 [163]. Recently, the group has proposed a 
workflow for AM digital information management to enable efficient and consistent digital 
thread transitions through the AM sub-processes – from design-to-product. The improved 
information management will allow for more transparent information exchange between the 
different AM sub-processes, ultimately supporting the notion of quality control throughout the 
development, manufacture, and qualification of an AM part [164].  
7 Future outlook  
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From the broader AM technologies perspective, future research should focus on issues 
listed in Table 2 to enable translational of research in AM technologies to real world 
applications.   
In the field of additive biomanufacturing, in addition to the technological barrier listed in table 
2, greater research efforts are needed to expedite the transformation from simple fabrication 
of scaffolds toward cell printing using bioinks. For fabrication of scaffold for TERM purposes, 
the research programme should focus on Designification & Scaffoldnification, which 
include, (a) biophysical requirements – scaffolds should inherit a sculpturous structural 
design, strength stability, degradation and cell-specific microarchitecture (e.g. pore shape, 
size and porosity), (b) biological requirements – cell loading density and spatial distribution, 
as well as cell attachment, growth and new tissue formation, (c) mass transport 
considerations – pore size, porosity, pores interconnectivity, (d) anatomical requirements- 
anatomical compatibility and geometry fitting, and (e) manufacturability requirements – 
process ability (e.g. biomaterial availability, printing feasibility, etc.) and process effects on 
the final printed part (e.g. residual stresses, material shrinkage, etc.).   
On the other hand, the research focus for cell printing should focus on: (a) the development 
of a new generation of biomaterials in the form of bioink that can simultaneously act as cell 
delivery matrix, cell support and perform as biomolecule to guide cell functionality, (b) 
converging the expertise from the field of developmental biology and biomechanical 
engineering to fill the biological knowledge gap, (c) expand the commercialisation of either 
the individual bioprinting tools or the entire additive technology platform to accelerate the 
maturation of the additive biomanufacturing field, enabling the fabrication of 3D 
heterogeneous structure in a viable, reliable and reproducible manner, and (d) explore four-
dimensional (4D) bioprinting models (embedded time into the 3D bioprinting models) to 
include cells with controlled release of biomolecules for complex tissues, organs, cellular 
machines and human-on-a-chip devices.  
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Figure captions: 
Figure 1 Structure of AM standards. Modified and adapted from [22]. 
Figure 2 Examples of scaffolds fabricated via additive manufacturing technologies used in 
large pre-clinical animal models for the evaluation of potential for (A – C) bone and (D – H) 
breast regeneration. (A) Cylindrical medical grade polycaprolactone (mPCL)-based scaffold 
implanted (reproduced with author’s permission [38]) into (B) sheep segmental defect modal 
(reproduced with author’s permission [39]). (C) Three months post-operatively, Bone 
regeneration was more pronounced in recombinant human-bone morphogenetic protein-7 
(rhBMP-7) group compared to scaffold-only and scaffold + mesenchymal stromal cells 
(MSCs) groups. (adapted from [40], Copyright permission obtained from The American 
Association for the Advancement of Science). (D) Hemisphere-shaped mPCL-scaffold 
implanted subcutaneously into minipigs for a period of six months. (E - H) Haematoxylin and 
Eosin (H&E) staining shows a long-standing regeneration of adipose tissue along with an 
extensive vascularisation within the scaffold pores (adapted from [41]). 
Figure 9 Example of scaffolds fabricated via additive manufacturing used clinically for the 
craniofacial reconstruction. (A – C) medical-grade polycaprolactone (mPCL) sheet moulded 
into the required shape by the surgeon prior to implantation. (D) Picture showing the 
implantation of moulded scaffold into a patient with orbital floor fractures. (E and F) X-ray 
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images before and after 2.5 years post-surgery, demonstrating complete bone regeneration 
at the defect site (adapted from [42] with copyright permission from John Wiley and Sons).  
Figure 4 Polymerisation route for the production of PLA. Modified and adapted from Auras 
et al. [54]. 
Figure 5 A variety of microstructure of lactides and PLAs. ROP, ring-opening polymerisation. 
Adapted from Masutani et al.[55].  
Figure 6 show the biomedical applications of non-medical and medical grade poly(lactides) 
dependent on the end-use. (a to c) showed the applicability of AM technologies in the 
biomedical engineering field. (a) Illustrated a hip implant prototype made of poly(D,L-lactic 
acid)(PDLLA) [38]. (b) Showed a PDLLA scaffolds used for proof-of-principle study for its’ 
potential in adipose tissue regeneration [59]. (c) Showed a custom-made rat bed for animal 
restrain during magnetic resonance imaging, demonstrating that PLA can be use for the 
manufacturing of low-cost laboratory consumables using AM technologies [66]. (d) Showed 
the ABSORB BVSTM scaffold [67] and orthopaedic screws and plate [68] made of medical-
grade PLA using conventional manufacturing technologies for clinical applications. 
Figure 7 Challenges for additive biomanufacturing. 
Figure 8 Digital Product development workflow. 
Tables: 
Table 1 List of Poly(lactides) (PLA)-based biomaterial used for fabrication of scaffolds using 
additive manufacturing (AM) technologies.  
AM technology PLA-based biomaterial Potential 
application 
Melt extrusion 
 
(a) PLA [64, 165, 166] 
(b) P(DLLA-co-CL) [72] 
(c) P(LLA-co-CL) [166, 167] 
(d) PLA/ silver nanoparticles composite 
[168] 
Breast scaffold 
[59, 72], surgical 
suture [167] 
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Solution extrusion 
 
(a) P(LLA-co-CL) [169, 170] 
(b) PLGA [171] 
(c) PLLA/ TCP composite [172] 
(d) PLGA/ pearl composite [173] 
Bone scaffold 
[172, 173], nerve 
guide [170] 
 
Selective laser 
sintering  
 
(a) PLA [174] 
(b) PLGA [175] 
(c) PLLA/hydroxyapatite [176, 177] 
(d) PDLLA/ribonuclease [178] 
Bone scaffold 
[174-177], Protein 
delivery [178] 
Stereolithography (a) PDLLA 3-FAME/NVP [179] 
(b) Methacrylate end-functionalised PDLLA 
[100, 180, 181] 
(c) Methacrylate end-functionalised 
P(DLLA-co-CL) [100] 
(d) Methacrylate end-functionalised PDLLA/ 
hydroxyapatite [182] 
Bone scaffold 
[182] 
PLLA: Poly(L-lactic acid), PDLLA: Poly(D,L-lactic acid), PLGA: Poly(L-lactide-co-glycolide), 
P(DLLA-co-CL): Poly(D,L-lactic acid-co-caprolactone), P(LLA-co-CL): Poly(L-lactic acid-co-
caprolactone), TCP: Tricalcium phosphate, FAME: Fumaric acid monoethyl ester, NVP: N-
vinyl-2- pyrrdidone
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Table 2 shows the material flexibility, cell printing capability and system limitation of various feeder system used in melt-extrusion based 3D 
printers. Additionally, high voltage electrical field (i.e. melt electrospinning writing) can be applied during the extrusion process to achieved 
thinner filaments. 
Melt-extrusion 3D 
printer 
Feeder system Melt electrospinning 
writing 
Filament Pneumatic Piston Screw 
Description 
Machine extrusion unit 
consist of a filament 
holding system. Material 
is converted into molten 
form just before it is 
extruded.  
Used of pressurised 
air/ gas for the 
extrusion of materials. 
Machine extrusion unit 
comprised of a pushing 
block which pushed the 
materials mechanically 
or pneumatically. 
Machine extrusion 
unit comprised of a 
screw head which 
pushed the materials 
by rotational force. 
Application of high 
voltage electrical field to 
achieve thin filaments (5 -
30 µm) during extrusion. 
Typically, pneumatic or 
piston feeder system are 
utilised.   
 
     
Material flexibility + +++ +++ +++ +++ 
Type of material 
Thermoplastic, 
composites 
Thermoplastic, composite, hydrogels 
Cell Printing No Yes Yes Yes Yes 
System limitations Require strong filaments Thermoplastic and composite: materials remain in molten form for extended period of time 
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Table 3 Comparison of pyrometers and thermocouples as tools for in-situ temperature 
measurement. Summarised from [151]. 
 Pyrometers Thermocouples 
Advantage  Contact-free measurement 
 Capable of detecting radiation 
emitted by moving object within 
focus boundary 
 Permit high spatial and temporal 
resolution measurement 
 Temperature range: 0 – 2000 °C 
 Less expensive compared to 
pyrometers 
 Do not require external power 
source 
 Small size 
 Temperature range: 0- 
1450 °C  
Disadvantage  Expensive 
 Large size 
 Difficulty in determining the 
radiation emissivity of monitored 
object 
 Require high computational 
power for data processing 
 Contact measurement 
 Delayed reaction time in 
detecting temperature 
fluctuation 
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Table 4 Technological Issues in additive manufacturing. 
Materials 
 Development of new materials for AM processes 
 Methods for materials mixing and formation to achieve the desired 
composition (e.g. composite, viscosity) and forms (e.g. powder, ink, 
slurry, filament) 
 Understand the interaction between materials and processes.  
Design 
 Development multi-functional design methods and tools to ease the 
design of part with complex geometries (macro-architecture) and 
  Enable inclusion of specific features (micro-architecture) (e.g. unit 
cells structures, gradient porosity/ pore sizes) and other design 
variations (e.g. multiple and gradient materials).   
Computation 
modelling 
 Establishment of mathematical computational models for: 
(a) temperature, stress, and composition history for understanding 
transport phenomena in AM processes (e.g., melting and 
recrystallization behavior of polymers) 
(b) prediction of microstructures and fatigue properties resulting 
from fibre reinforced design 
(c) multi-scale modeling for more accurate prediction of complex 
process-structure-property relationships 
(d) modeling of layer-to-layer bonding between homogeneous and 
heterogeneous materials, and  
(e) reduction of complex process models to lower-order models for 
the purpose of real-time control of AM processes. 
Sensing and 
control 
 Development of real time in-process sensing tools, which include but 
not limited to: 
(a) optical measurement of geometric dimensions and surface quality 
of finished layers,  
(b) in-process multi-band spectroscopic analysis of AM by-products 
 Understanding the correlation between computational model 
predictions and AM processes (temperature, humidity, residual 
stresses etc.)  
 Integration of real-time sensing and closed-loop control of AM 
processes.  
Process 
innovation 
 Establishment of a streamline digital product manufacturing workflow 
 Improve the AM material deposition rate by orders of magnitude for 
fabrication of large-scale and/or large volume parts. 
System 
integration 
 Integration of interdisciplinary knowledge rooted in fundamental 
sciences for AM system development 
 Establishment of cyberspace-enabled and cloud-based sharing of 
AM and other innovative manufacturing resources.   
 
